Pharmafile Logo
Pharmafocus logo
Advanced Search
antibiotics

Give GPs feedback on prescribing habits to reduce antibiotic use, says study

February 18, 2016
Medical Communications, Research and Development antimicrobial resistance

A trial of more than 1,500 GP practices has shown that sending general practitioners (GPs) letters giving feedback on their …

News
gilead-sciences

FDA approves Gilead’s Harvoni in two new indications

February 18, 2016
Research and Development Gilead Sciences, MSD, harvoni, hepatitis C

The hepatitis C treatment battle had its latest development yesterday, with the FDA awarding Gilead Science’s market-leading drug Harvoni (ledipasvir/sofosbuvir) …

News
az_logo_on_building

AZ’s durvalumab awarded breakthrough status in bladder cancer

February 18, 2016
Research and Development AstraZeneca, FDA, bladder cancer

AstraZeneca, and its biologics/R&D arm MedImmune, have won FDA Breakthrough Therapy status for their bladder cancer drug durvalumab (MEDI4736), which …

News
malcolm_farnan

MPS appoints global marketing leader

February 17, 2016
Manufacturing and Production

Multi Packaging Solutions International, a global leader in value-added print and packaging solutions for the branded consumer, healthcare and multi-media …

Appointment

Pfizer pays $784m to settle Protonix overcharge claims

February 17, 2016
Research and Development, Sales and Marketing Medicaid, Pfizer, Wyeth, protonix

US drugs giant Pfizer is to pay more than $784 million to settle claims that it overcharged health insurer Medicaid …

News

FDA gives Roche MS drug breakthrough status

February 17, 2016
Research and Development Genentech, MS, Roche

Roche subsidiary Genentech has been awarded US Food and Drug Administration (FDA) Breakthrough Therapy Designation for its drug Ocrevus (ocrelizumab) …

News
image_via_the_dementia_consortium

AbbVie becomes Dementia Consortium’s latest pharma partner

February 16, 2016
Manufacturing and Production, Research and Development

AbbVie has become the latest pharmaceutical company to join The Dementia Consortium- a £4 million global collaboration aiming to speed …

News
brexit

What would BREXIT mean for pharma?

February 16, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing research and development

It began with a promise to UK voters to end ‘benefit tourism’ and to negotiate more flexibility in the UK’s …

Feature
samsung_bioepis

First Enbrel biosimilar launches in UK

February 16, 2016
Manufacturing and Production, Research and Development Enbrel, Samsung Bioepis, eternacept, rheumatoid arthritis

Following its approval by the European Commission in January, Benepali has become the first biosimilar of Pfizer/Amgen’s Enbrel (etanercept) to …

News
eli_lilly

Lilly suffers damaging Alimta patent blow

February 15, 2016
Manufacturing and Production, Sales and Marketing Actavis, Alimta, Allergan, Eli Lilly, pemetrexed

Eli Lilly says it plans to appeal a UK High Court’s verdict that could imminently open its blockbuster lung cancer …

News
cancer_cells_blue

New 10-minute test will diagnose cancer at home

February 15, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Cancer

Scientists have developed a test for cancer that can diagnose the disease at home with the aid of just a …

News
hilary_clinton_speaks_at_a_rally_in_des_moines_in_january

FEC stats reveal pharma donations to presidential runners

February 12, 2016
Sales and Marketing

Stats from the Center for Responsive Politics and the Federal Election Commission (FEC), have revealed the extent of donations from the …

News
opdivo

UK patients get early access to Opdivo for kidney cancer

February 12, 2016
Medical Communications, Sales and Marketing

Bristol Myers-Squibb’s Opdivo (nivolumab) will be available through the Early Access to Medicines  Scheme (EAMS) as a monotherapy to UK …

News
amgen_flag

Amgen’s Kyprolis now available to UK multiple myeloma patients

February 12, 2016
Medical Communications, Sales and Marketing Amgen, Kyprolis, multiple myeloma

Amgen has announced the UK launch of Kyprolis (carfilzomib) in combination with Revlimid (lenalidomide) and dexamethasone for the treatment of …

News
fda

Biosimilars: Can the US catch up in 2016?

February 12, 2016
Medical Communications, Sales and Marketing Eli Lilly, Enbrel, FDA, Neulasta, Novartis, Pfizer, Sandoz, Zarxio, biosimilars

What are biosimilars? Biosimilars are essentially the biological equivalent of generic drugs to their branded small-molecule counterparts (what Ibuprofen is …

Feature
gsk_good_smaller

GSK fined millions over deals to delay generic competition

February 12, 2016
Medical Communications, Sales and Marketing GSK seroxat

GlaxoSmithKline has been fined £37.6m by the UK Competition & Markets Authority (CMA) for paying two generic drugmakers to delay …

News
sandoz_good

Sandoz buys rights to Pfizer biosimilar

February 12, 2016
Medical Communications, Research and Development, Sales and Marketing Pfiizer, Sandoz, biosimilars

Sandoz has announced further expansion to its biosimilars programme with the acquisition of the European rights to Pfizer’s Remicade (infliximab) …

News
incyte

Incyte to stop Jakafi pancreatic, colorectal cancer drug trials

February 11, 2016
Research and Development Incyte, Jakafi, Jakavi, Novartis, Pancreatic cancer, colorectal cancer

Incyte said today that it is terminating its JANUS clinical trial programme testing blood cancer drug Jakafi in solid tumours …

News
abpi_logo

ABPI appoints Mike Thompson as new chief executive

February 11, 2016
Medical Communications

The Association of the British Pharmaceutical Industry (ABPI) has appointed former GlaxoSmithKline executive Mike Thompson as its new chief executive …

Appointment
gene

Genomics England enters bioinformatics partnership with Illumina

February 11, 2016
Research and Development Genomics england, Illumia

Genomics England has announced a new partnership with US-based sequencing specialist Illumina to develop a platform and knowledge base that …

News
The Gateway to Local Adoption Series

Latest content

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026

Incyclix Bio announces new additions to the Board

April 22, 2026

Remedy Plan Therapeutics Appoints Jotin Marango as CFO and CBO

April 21, 2026